Clover Health Investments (CLOV) Income towards Parent Company (2019 - 2026)

Clover Health Investments (CLOV) has 7 years of Income towards Parent Company data on file, last reported at $27.3 million in Q1 2026.

• For the quarter ending Q1 2026, Income towards Parent Company changed N/A year-over-year to $27.3 million; the trailing twelve-month figure through Mar 2026 stood at $27.3 million (up 4004.86% YoY), and the FY2024 full-year result was $3.3 million, up 203.12% from the prior year.
• Income towards Parent Company for Q1 2026 stood at $27.3 million, up from -$568000.0 in the prior quarter.
• Across five years, Income towards Parent Company topped out at $27.3 million in Q1 2026 and bottomed at -$103.1 million in Q2 2022.
• The 4-year median for Income towards Parent Company is -$568000.0 (2024), against an average of -$20.0 million.
• Peak annual rise in Income towards Parent Company reached 217.33% in 2024, while the deepest fall reached 43.6% in 2024.
• A 4-year view of Income towards Parent Company shows it stood at -$22.5 million in 2022, then soared by 88.82% to -$2.5 million in 2023, then soared by 77.41% to -$568000.0 in 2024, then surged by 4912.32% to $27.3 million in 2026.
• The last three Income towards Parent Company figures came in at $27.3 million (Q1 2026), -$568000.0 (Q4 2024), and -$370000.0 (Q3 2024), per Business Quant data.

Peer Comparison